Press Release: Obatala : Obatala Sciences Announces Commercial Launch of Its ObaCell Obesity-on-a-Chip Service

NEW ORLEANS--(BUSINESS WIRE)--Obatala Sciences, a biotechnology company that manufactures stem cells and human-derived hydrogels, announced the accomplishment of a major milestone with the commercial launch of its ObaCell® Obesity-on-a-Chip Service. The new service reflects the commercial development of a family of patents that Obatala licensed from Harvard University in 2021. Obatala Sciences is one of several companies that have commercialized new models of human tissue and organs, called mic